ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids
about
Perforin-low memory CD8+ cells are the predominant T cells in normal humans that synthesize the beta -chemokine macrophage inflammatory protein-1betaPotent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccinationEvidence of HIV exposure and transient seroreactivity in archived HIV-negative severe hemophiliac sera.Resistance to HIV InfectionDynamics of the CD8 T-cell response following yellow fever virus 17D immunizationReduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmissionModelling HIV immune response and validation with clinical data.Brief Report: HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis TrialInduction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimenInfection with HIV-1.Inhibition of human immunodeficiency virus type 1 replication in primary CD4(+) T lymphocytes, monocytes, and dendritic cells by cytotoxic T lymphocytes.Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates.Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificitiesHuman immunodeficiency virus (HIV)-specific cellular immune responses in newborns exposed to HIV in utero.Flow cytometry and T-cell response monitoring after smallpox vaccination.The quest for an AIDS vaccine: is the CD8+ T-cell approach feasible?Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response.Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals.Innate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls.Evidence that high-dosage zidovudine at time of retrovirus exposure reduces antiviral efficacyIncreased APOBEC3G and APOBEC3F expression is associated with low viral load and prolonged survival in simian immunodeficiency virus infected rhesus monkeys.Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.HIV-1 vaccines and co-infection.Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanismsProtection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission.Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus.Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergyComparison of sexual behavior and HIV risk between two HIV-1 serodiscordant couple cohorts: the CHAVI 002 study.Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses.Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants.Vaccine strategies for infectious diseases.Global human genetics of HIV-1 infection and China.Protective immunity against hepatitis C virus infection.
P2860
Q24555821-1514201B-7F96-4905-8335-ECE53DBAF89EQ24646818-B84471F6-A59C-405C-B6D6-55545C10F408Q24815966-EE8B4A4F-83C0-41C3-916C-CC816F43C56FQ27473466-A44F8BFD-2CF5-40CF-9396-B5159A14D231Q27489813-381BADD6-667D-4925-89C3-D13F6FF1ECA4Q28362322-C40D006B-DE6D-41B4-8E4A-602B9CC57B06Q33460449-2A579804-95E4-4461-8A2C-310E64148C27Q33574027-6763E685-AD4A-4F11-90AF-CD7132FAFA12Q33611645-CD4783A4-29FB-466E-907F-5574129DDCE8Q33649842-FB2B6D6B-8641-411E-B190-8CA6ACC14900Q33792479-7BD9D074-BCBE-466E-8053-8395A1F68872Q33808351-685DABEA-C527-4902-8058-13B9B4ACB699Q33808774-6F254598-CF0E-49DA-8578-1C1F3F8BDBC2Q33839448-5D48B580-9320-422D-B685-53F4451B1E5EQ33839981-B6415284-1990-47F6-9211-2AC6D7C556C2Q33854564-31393BC7-7901-4FA5-BE09-A767B4A6980CQ33939974-24221BEC-1D85-457F-9AD6-C09122B588DDQ34461381-6A177E0C-33F3-4F5B-94F5-44DC75DD31F3Q34560132-9F8AC64A-0204-4BB3-8B1E-7E64574658FAQ34632089-9EB99586-A28D-4CB6-B0B0-AA8799794D5DQ34949513-D0FB441A-1FF0-4C6B-8B9F-42F0A5287CF4Q34996361-0C83B1FC-74ED-494A-9373-39A6B54F94A4Q35085106-0398704B-FAD1-42ED-AC93-E78E8504FCC0Q35127088-D163E002-BDB2-44D3-B5A2-2A9AE4BF943AQ35339284-5A515A67-B5A4-4D02-B072-D345DE14BE3DQ35372676-1DE69508-37A3-4333-95B2-E994702E7708Q35635083-5C524A30-C1AC-45A0-B283-47C282507452Q35828692-05F1B231-841C-46DD-BA31-1B39EE4EF8D8Q35873784-826C8940-7366-417C-B724-DADF23FEA02AQ35881271-BADEEEE1-6BDE-4DD4-AB78-5B7EE0255375Q35887675-1F7BCED0-1103-48A2-844B-C71A0218A670Q35895851-03B3CD5E-0D7D-406C-8D8E-EFAB52C1DBADQ35898707-1DEDF67A-AAD1-4C2A-AD18-CC5303EBB5FAQ35920663-D0EAA32F-704C-4DC1-ADB8-303BC71E7BABQ35980347-8BF333D6-5115-484E-A1CB-ECF20CE28128Q36010671-70573146-7B89-416C-BF6A-BE0B20E419ECQ36055506-4F032711-AB80-4DED-BB85-2FDA15FC1372Q36181264-BC6476E0-F7EF-4859-B8B8-0EE8D3790A27Q36342033-C6592394-EA4F-45CE-AD62-BF68110ADEDFQ36410459-8C311838-407D-4FA1-A7BD-53FCEC9932BD
P2860
ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids
description
1995 nî lūn-bûn
@nan
1995 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
ENV-specific cytotoxic T lymph ...... o HIV-contaminated body fluids
@ast
ENV-specific cytotoxic T lymph ...... o HIV-contaminated body fluids
@en
ENV-specific cytotoxic T lymph ...... o HIV-contaminated body fluids
@nl
type
label
ENV-specific cytotoxic T lymph ...... o HIV-contaminated body fluids
@ast
ENV-specific cytotoxic T lymph ...... o HIV-contaminated body fluids
@en
ENV-specific cytotoxic T lymph ...... o HIV-contaminated body fluids
@nl
prefLabel
ENV-specific cytotoxic T lymph ...... o HIV-contaminated body fluids
@ast
ENV-specific cytotoxic T lymph ...... o HIV-contaminated body fluids
@en
ENV-specific cytotoxic T lymph ...... o HIV-contaminated body fluids
@nl
P2093
P2860
P921
P356
P1476
ENV-specific cytotoxic T lymph ...... o HIV-contaminated body fluids
@en
P2093
A L Landay
G M Shearer
H A Kessler
J A Berzofsky
J Sullivan
P2860
P304
P356
10.1172/JCI118133
P407
P577
1995-08-01T00:00:00Z